• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官短缺时期肝移植等待名单上高死亡率的危险因素:单中心分析

Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis.

作者信息

Husen Peri, Hornung Julian, Benko Tamas, Klein Christian, Willuweit Katharina, Buechter Matthias, Saner Fuat Hakan, Paul Andreas, Treckmann Juergen Walter, Hoyer Dieter Paul

机构信息

Department of General, Visceral and Transplantation Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

出版信息

Ann Transplant. 2019 May 3;24:242-251. doi: 10.12659/AOT.914246.

DOI:10.12659/AOT.914246
PMID:31048668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6519305/
Abstract

BACKGROUND Germany has the highest rate of patients dying or becoming unfit for transplant while waitlisted within the Eurotransplant region. Therefore, the aim of the current study was to analyze mortality as well as risk factors for mortality of candidates listed for liver transplantation at our center. MATERIAL AND METHODS Between 01/2011 and 12/2013, 481 adult patients were listed for primary liver transplantation (LT) at a single German center. Clinical and laboratory parameters were prospectively collected and retrospectively analyzed by univariable and multivariable logistic regression and Cox proportional hazards. RESULTS The mean model for end-stage liver disease (MELD) score of all liver transplant waitlist registrants (52.4 years, 60.1% male) was 16.9 (±10.2) at time of listing, with 10% of the listed patients having a MELD score of >32. After waitlisting, 133 (27.7%) candidates died within the follow-up period. Three-month-survival after listing for transplantation was 89% for patients ultimately receiving LT vs. 71.2% that did not receive LT (p<0.001). Multivariable analysis identified clinical parameters such as ICU treatment, preceding abdominal surgery, variceal bleeding, and ascites, as well as hydropic decompensation, as independent risk factors for waitlist mortality. CONCLUSIONS Consideration of independent risk factors of mortality within the MELD-based allocation system potentially improves assessment of individual urgency and might improve utilization of available organs.

摘要

背景 在欧洲移植区域内,德国等待移植的患者死亡率或不再适合移植的比例最高。因此,本研究的目的是分析我院中心等待肝移植患者的死亡率及其死亡风险因素。材料与方法 2011年1月至2013年12月期间,德国一家中心有481例成年患者被列入首次肝移植(LT)名单。前瞻性收集临床和实验室参数,并通过单变量和多变量逻辑回归以及Cox比例风险模型进行回顾性分析。结果 所有等待肝移植登记患者(52.4岁,60.1%为男性)在列入名单时的终末期肝病平均模型(MELD)评分为16.9(±10.2),其中10%的列入名单患者MELD评分>32。列入名单后,133例(27.7%)候选者在随访期内死亡。最终接受肝移植的患者移植列入名单后三个月生存率为89%,未接受肝移植的患者为71.2%(p<0.001)。多变量分析确定了诸如重症监护病房治疗、先前腹部手术、静脉曲张出血和腹水以及水肿性失代偿等临床参数为等待名单死亡率的独立风险因素。结论 在基于MELD的分配系统中考虑死亡率的独立风险因素可能会改善对个体紧迫性的评估,并可能提高可用器官的利用率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d0e/6519305/7e799fa878e3/anntransplant-24-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d0e/6519305/7e799fa878e3/anntransplant-24-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d0e/6519305/7e799fa878e3/anntransplant-24-242-g001.jpg

相似文献

1
Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis.器官短缺时期肝移植等待名单上高死亡率的危险因素:单中心分析
Ann Transplant. 2019 May 3;24:242-251. doi: 10.12659/AOT.914246.
2
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.终末期肝病模型评分低的肝移植候选者的结局
Liver Transpl. 2015 Nov;21(11):1403-9. doi: 10.1002/lt.24307.
3
Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.高 MELD 评分和严重肝性脑病的肝移植候选者的候补名单结局。
Dig Dis Sci. 2018 Jun;63(6):1647-1653. doi: 10.1007/s10620-018-5032-5. Epub 2018 Apr 2.
4
Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.胆道闭锁年轻患者的候补名单死亡率:基于欧洲器官移植登记处队列的竞争风险分析。
Liver Transpl. 2018 Jun;24(6):810-819. doi: 10.1002/lt.25025.
5
Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.巴西圣保罗的肝脏分配测试:终末期肝病模型实施与等待名单死亡率降低之间的关系。
Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.
6
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.中等量腹水可识别出等待肝移植的低终末期肝病模型评分患者,此类患者具有较高的死亡风险。
Liver Transpl. 2011 Feb;17(2):129-36. doi: 10.1002/lt.22218.
7
Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.终末期肝病模型评分40分患者肝移植的单中心经验
Dig Dis Sci. 2016 Nov;61(11):3346-3353. doi: 10.1007/s10620-016-4274-3. Epub 2016 Aug 18.
8
The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.发展中国家的终末期肝病模型(MELD)系统与肝移植等待名单上的死亡率:来自巴西圣保罗的经验教训。
Einstein (Sao Paulo). 2012 Jul-Sep;10(3):278-85. doi: 10.1590/s1679-45082012000300004.
9
Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.原发性胆汁性肝硬化患者在日本移植分配系统中的候补者死亡率。
J Gastroenterol. 2014 Feb;49(2):324-31. doi: 10.1007/s00535-013-0782-5. Epub 2013 Mar 12.
10
Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.等待肝移植患者的器官分配不平等:取消终末期肝病模型配型限制的理由。
J Hepatol. 2017 Sep;67(3):517-525. doi: 10.1016/j.jhep.2017.04.022. Epub 2017 May 5.

引用本文的文献

1
Amniotic fluid reduces liver fibrosis by attenuating hepatic stellate cell activation.羊水通过减弱肝星状细胞激活来减轻肝纤维化。
Stem Cells Transl Med. 2025 Jun 25;14(7). doi: 10.1093/stcltm/szaf026.
2
Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review.酒精相关肝病患者的酒精使用障碍药物治疗:一项范围综述
Can J Gastroenterol Hepatol. 2025 Apr 3;2025:6455092. doi: 10.1155/cjgh/6455092. eCollection 2025.
3
Amniotic Fluid Reduces Liver Fibrosis By Attenuating Hepatic Stellate Cell Activation.

本文引用的文献

1
2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation.2018 年欧洲肝移植注册处(ELTR)年度报告——肝移植 50 年的发展历程。
Transpl Int. 2018 Dec;31(12):1293-1317. doi: 10.1111/tri.13358.
2
Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time.肝移植中风险因素及模型预测能力随时间的识别与验证
Transplant Direct. 2018 Aug 21;4(9):e382. doi: 10.1097/TXD.0000000000000822. eCollection 2018 Sep.
3
Evolution of Deceased Organ Donation Activity Versus Efficiency Over a 15-year Period: An International Comparison.
羊水通过减弱肝星状细胞激活来减轻肝纤维化。
bioRxiv. 2025 Feb 20:2025.02.20.639215. doi: 10.1101/2025.02.20.639215.
4
A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver Failure.一项非随机试点研究,旨在调查LivR Well的可接受性和可行性:一项针对慢性肝衰竭急性发作的为期28天的多方面居家肝脏优化计划。
Gastro Hep Adv. 2024 Oct 18;4(2):100567. doi: 10.1016/j.gastha.2024.10.007. eCollection 2025.
5
Safety and efficacy of Single-Pass Albumin Dialysis (SPAD), Prometheus, and Molecular Adsorbent Recycling System (MARS) liver haemodialysis vs. Standard Medical Therapy (SMT): meta-analysis and systematic review.单次通过白蛋白透析(SPAD)、普乐可复(Prometheus)和分子吸附再循环系统(MARS)肝脏血液透析与标准药物治疗(SMT)的安全性和有效性:荟萃分析与系统评价
Prz Gastroenterol. 2024;19(2):101-111. doi: 10.5114/pg.2024.139297. Epub 2024 Apr 29.
6
Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.利福昔明降低患有肝性脑病的肝硬化肝移植候选者全因住院风险。
J Clin Med. 2023 Oct 31;12(21):6871. doi: 10.3390/jcm12216871.
7
The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model.使用马尔可夫多状态模型评估预后因素对终末期肝病患者移植及死亡率的影响。
J Res Med Sci. 2023 Apr 6;28:28. doi: 10.4103/jrms.jrms_1091_21. eCollection 2023.
8
Hyperspectral Imaging for Viability Assessment of Human Liver Allografts During Normothermic Machine Perfusion.用于常温机器灌注期间人同种异体肝移植活力评估的高光谱成像技术
Transplant Direct. 2022 Nov 17;8(12):e1420. doi: 10.1097/TXD.0000000000001420. eCollection 2022 Dec.
9
Alcoholic liver disease: a new insight into the pathogenesis of liver disease.酒精性肝病:对肝病发病机制的新认识。
Arch Pharm Res. 2022 Jul;45(7):447-459. doi: 10.1007/s12272-022-01392-4. Epub 2022 Jun 27.
10
Effect of COVID-19 on liver transplantation in Korea.新型冠状病毒肺炎对韩国肝移植的影响。
Transpl Infect Dis. 2020 Oct;22(5):e13384. doi: 10.1111/tid.13384. Epub 2020 Jul 13.
15 年间器官捐献活动的演变与效率:国际比较。
Transplantation. 2018 Oct;102(10):1768-1778. doi: 10.1097/TP.0000000000002226.
4
OPTN/SRTR 2016 Annual Data Report: Deceased Organ Donation.OPTN/SRTR 2016 年度数据报告:已故器官捐赠。
Am J Transplant. 2018 Jan;18 Suppl 1:434-463. doi: 10.1111/ajt.14563.
5
[Acceptance of post-mortem organ donation in Germany : Representative cross-sectional study].[德国对死后器官捐赠的接受情况:代表性横断面研究]
Anaesthesist. 2018 Feb;67(2):118-125. doi: 10.1007/s00101-017-0391-4. Epub 2017 Dec 11.
6
Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.定义肝移植的基准:一项多中心结局分析确定最佳可实现结果。
Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.
7
How Spain Reached 40 Deceased Organ Donors per Million Population.西班牙如何实现每百万人中有 40 名已故器官捐献者。
Am J Transplant. 2017 Jun;17(6):1447-1454. doi: 10.1111/ajt.14104. Epub 2017 Jan 9.
8
Adult Liver Allocation in Eurotransplant.欧洲肝移植中的成人肝脏分配。
Transplantation. 2017 Jul;101(7):1542-1550. doi: 10.1097/TP.0000000000001631.
9
Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era?评估原位肝移植术后20年的随访情况,供体-受体匹配的最佳实践:我们能从过去的时代中学到什么?
World J Transplant. 2016 Sep 24;6(3):599-607. doi: 10.5500/wjt.v6.i3.599.
10
Liver transplantation in Germany.德国的肝移植
Liver Transpl. 2016 Aug;22(8):1136-42. doi: 10.1002/lt.24461.